Risk-based Approaches for Optimizing Treatment in HER2-Positive Early Stage Breast Cancer-Reference-Cited by-同舟云学术

Risk-based Approaches for Optimizing Treatment in HER2-Positive Early Stage Breast Cancer

Published:2020-10 Issue:5 Volume:47 Page:249-258
ISSN:0093-7754
Container-title:Seminars in Oncology
language:en
Short-container-title:Seminars in Oncology

Author:

Chiec Lauren^ORCID,Shah Ami N.^ORCID

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference72 articles.

1. Cancer incidence and survival trends by subtype using data from the surveillance epidemiology and end results program, 1992-2013;Noone;Cancer Epidemiol Biomarkers Prev,2017

2. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene;Slamon;Science,1987

3. Breast Cancer Facts and Figures 2019-2020. [PDF] [cited2020April 26]; Available at:https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/breast-cancer-facts-and-figures/breast-cancer-facts-and-figures-2019-2020.pdf.

4. neu/erbB-2 amplification identifies a poor-prognosis group of women with node-negative breast cancer. Toronto Breast Cancer Study Group.;Andrulis;J Clin Oncol,1998

5. A novel HER2-positive breast cancer phenotype arising from germline TP53 mutations;Wilson;J Med Genet,2010

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term outcomes of a randomized, open-label, phase II study comparing cabazitaxel versus paclitaxel as neoadjuvant treatment in patients with triple-negative or luminal B/HER2-negative breast cancer (GENEVIEVE);ESMO Open;2024-05

2. Analysis of Genomic Alterations Associated with Recurrence in Early Stage HER2-Positive Breast Cancer;Cancers;2022-07-27

3. Targeting HER2+ Breast Cancer Brain Metastases: A Review of Brain-Directed HER2-Directed Therapies;CNS Drugs;2022-01-25

4. Pathological Response in the Breast and Axillary Lymph Nodes after Neoadjuvant Systemic Treatment in Patients with Initially Node-Positive Breast Cancer Correlates with Disease Free Survival: An Exploratory Analysis of the GeparOcto Trial;Cancers;2022-01-20

5. Traditional Chinese Medicine for adjuvant treatment of breast cancer: Taohong Siwu Decoction;Chinese Medicine;2021-12